Vivos Inc. Provides 2020 Recap and Outlines 2021 Objectives
(Thu, 28, Jan, 2021) >> read more

Vivos Inc Receives Feedback from FDA on Breakthrough Designation Request
(Tue, 19, Jan, 2021) >> read more

Vivos Inc Completes Surrogate Lymph Node Testing Using Mouse Spleen Injections Demonstrating Uniform Perfusion and Stability
(Wed, 09, Dec, 2020) >> read more

Vivos Inc to Present at The 13th Annual LD Micro Main Event Conference December 15, 2020 11:00 AM Eastern Standard Time
(Mon, 07, Dec, 2020) >> read more

Vivos Inc Extends it Intellectual Property Protection
(Tue, 01, Dec, 2020) >> read more

Vivos Inc Applies for Breakthrough Device Designation for Radiogelâ„¢
(Fri, 20, Nov, 2020) >> read more